Market Cap (In USD)
11.13 Million
Revenue (In USD)
-
Net Income (In USD)
98 Thousand
Avg. Volume
17.21 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.06-0.24
- PE
- -
- EPS
- -
- Beta Value
- 0.483
- ISIN
- US2939041081
- CUSIP
- 293904108
- CIK
- 727510
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Richard L. Feinstein CPA
- Employee Count
- -
- Website
- https://www.enzon.com
- Ipo Date
- 1984-02-15
- Details
- Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.
More Stocks
-
FZR
-
JRONF
-
IDEXIDEX Biometrics ASA
IDEX
-
PHOTON
-
RANI3
-
COLORCHIPSCOLORCHIPS NEW MEDIA LIMITED
COLORCHIPS
-
BTR
-
600303